What To-be-discard Biomaterials From ART Cycles Can Tell us About the Treatment Cycle Outcome?
Study Overview
Status
Status
Conditions
Conditions
Detailed Description
Study Type
Study Type
Enrollment (Estimated)
Enrollment
Contacts and Locations
Study Contact
Study Contact
- Name: Yiu Leung D Chan, DPhil
- Phone Number: (852) 3505 3199
- Email: drdcyl16@cuhk.edu.hk
Study Locations
-
-
-
Hong Kong, Hong Kong
- Recruiting
- The Chinese University of Hong Kong and Prince of Wales Hospital
-
Contact:
- Yiu Leung D Chan, DPhil
- Phone Number: (852) 3505 3199
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Patients attending the Assisted Reproductive Technology (ART) Unit of the Chinese University of Hong Kong for ART treatment.
- Participant able to give voluntary, written, informed consent to participate in the study.
Exclusion Criteria:
- Patient using donor gamete in IVF treatment
- Patient refuses to join and failed to giving consent for any reasons
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
DNA/RNA sequencing data
Time Frame: Through study completion, around 3 year
|
DNA / RNA analysis including the length and the quantity, RNA-seq will be applied for transcriptome profiling.
Next generation sequencing will be performed to determine the sequence of DNA/RNA for our collected samples.
|
Through study completion, around 3 year
|
|
Proteomic profile
Time Frame: Through study completion, around 3 year
|
Protein profile will be investigated in a pool sample, treated samples will go for mass spectrometry (MS) data acquisition and finally destined for data analysis and interpretation.
|
Through study completion, around 3 year
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Blastocyst formation rate
Time Frame: 5 days after fertilization
|
Number of blastocysts out of fertilized oocytes observed 5 days after fertilization
|
5 days after fertilization
|
|
Clinical pregnancy rate
Time Frame: Around 5 weeks after embryo transfer
|
Clinical pregnancy confirmed by ultrasound
|
Around 5 weeks after embryo transfer
|
|
Live birth rate
Time Frame: Around 9 months after embryo transfer
|
Birth of a living infant after embryo transfer
|
Around 9 months after embryo transfer
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Principal Investigator: Yiu Leung D Chan, DPhil, CUHK
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Estimated)
Primary Completion
Study Completion (Estimated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- 2023.066
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.